 SAN DIEGO, July 29, 2020 GLOBE NEWSWIRE -- Histogen Inc. NASDAQ: HSTO, a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the bodys natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the Canaccord Genuity 40th Annual Growth Conference. The virtual presentation is scheduled for Wednesday, August 12, 2020 at 1:30 p.m. Eastern Time. Presentation Details Date: Wednesday August 12, 2020 Time: 1:30 p.m. Eastern Time 10:30 a.m. Pacific Time Live Webcast Link: those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on Histogen Inc.Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the bodys natural process to repair and maintain healthy biological function. Histogens innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogens proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair. For more information, please visit A. Knudson Executive Vice President CFO Histogen Inc. 